Recombinant Salmonella choleraesuis Putative protein-disulfide oxidoreductase (SCH_3138)

What is the functional role of putative protein-disulfide oxidoreductase (SCH_3138) in Salmonella choleraesuis?

Protein disulfide oxidoreductases are ubiquitous redox enzymes that catalyze dithiol-disulfide exchange reactions, characterized by CXXC sequence motifs at their active sites . SCH_3138, as a putative protein-disulfide oxidoreductase in Salmonella choleraesuis, likely facilitates the formation, reduction, and isomerization of disulfide bonds in bacterial proteins. Similar enzymes in other organisms demonstrate both oxidative/reductive activity and isomerase activity, with distinct functional contributions from each active site . In bacterial systems, these enzymes typically contribute to proper protein folding, particularly for secreted virulence factors and surface proteins that require disulfide bonds for structural stability.

Methodological approach: To confirm the functional role of SCH_3138, researchers should:

• Perform sequence alignment with characterized protein-disulfide oxidoreductases

• Identify conserved CXXC motifs

• Conduct redox activity assays using standard substrates like insulin

• Measure both oxidase and reductase activities using appropriate redox-sensitive fluorescent probes

• Create knockout mutants to assess phenotypic changes

How should researchers approach the cloning and expression of recombinant SCH_3138?

When cloning and expressing SCH_3138, researchers should consider the following methodological approach:

• Gene identification and primer design: Use whole-genome sequences of Salmonella choleraesuis to identify the SCH_3138 gene and design primers with appropriate restriction sites.

• Expression vector selection: Select vectors similar to pYA3943, which contains balanced lethal systems (e.g., asd gene complementation) for stable maintenance in attenuated Salmonella strains .

• Verification protocol:

  • Confirm successful construction by PCR amplification

  • Verify using restriction enzyme digestion (e.g., EcoRI and SalI)

  • Validate by DNA sequencing

  • Confirm protein expression via Western blot analysis using appropriate antisera

• Stability assessment: Evaluate plasmid stability through serial passages (at least 50 generations) with restriction digestion verification at regular intervals .

Expression parameters table:

What experimental design is optimal for characterizing the enzymatic properties of SCH_3138?

A comprehensive experimental design for characterizing SCH_3138 should include:

• Purification strategy:

  • IMAC (immobilized metal affinity chromatography) for His-tagged constructs

  • Size exclusion chromatography for final polishing

  • Quality assessment via SDS-PAGE and Western blotting

• Enzymatic activity assays:

  • Oxidative activity: insulin turbidity assay

  • Reductive activity: DTNB (5,5'-dithiobis-(2-nitrobenzoic acid)) reduction

  • Isomerase activity: scrambled RNase refolding assay

• Kinetic parameters determination:

  • Substrate concentration series

  • Temperature and pH optima determination

  • Metal ion dependence evaluation

• Site-directed mutagenesis of CXXC active sites to determine the specific roles of each redox site, similar to the C35S and C146S mutations approach used for PfPDO .

Following the experimental design principles in search result , researchers should:

• Clearly define independent variables (e.g., substrate concentration, pH, temperature)

• Identify dependent variables (e.g., enzymatic activity rates)

• Control extraneous variables (e.g., buffer composition, protein purity)

• Utilize appropriate controls (e.g., heat-inactivated enzyme, known PDO enzymes)

How can researchers differentiate between the oxidase, reductase, and isomerase activities of SCH_3138?

The differentiation between multiple enzymatic activities requires specific assays for each function:

• Oxidase activity measurement:

  • Monitor the formation of disulfide bonds in reduced peptide substrates

  • Use fluorescence-quenched peptide substrates where fluorescence increases upon oxidation

  • Quantify using spectrofluorometric methods

• Reductase activity assessment:

  • Measure the reduction of disulfide-containing substrates

  • Use DTNB assay to detect free thiols generated

  • Monitor decrease in absorbance at 340 nm with NADPH as electron donor

• Isomerase activity evaluation:

  • Use scrambled RNase A with incorrect disulfide bonds

  • Measure recovery of RNase activity as indication of isomerase function

  • Monitor spectrophotometrically using cCMP (cytidine 2',3'-cyclic monophosphate) as substrate

Comparative activity table for interpretation:

How can researchers assess the role of SCH_3138 in Salmonella choleraesuis virulence?

To evaluate SCH_3138's contribution to virulence:

• Generate defined mutants:

  • Create SCH_3138 knockout strain using lambda Red recombinase system

  • Develop active site mutants (CXXC to CXXS) to preserve structure but eliminate function

  • Complement with wild-type SCH_3138 on a plasmid for verification

• In vitro virulence assays:

  • Adhesion and invasion assays using epithelial cell lines

  • Survival within macrophages

  • Biofilm formation capacity

  • Resistance to oxidative stress (H₂O₂ challenge)

• Mouse model studies:

  • Compare colonization of wild-type vs. mutant strains

  • Assess bacterial burden in organs (spleen, liver, Peyer's patches)

  • Measure survival rates following intraperitoneal challenge

  • Evaluate tissue pathology

• Transcriptomic/proteomic analysis:

  • RNA-Seq to identify differentially expressed genes in the mutant

  • Proteomic analysis focusing on secreted proteins and surface structures

  • Identify misfolded proteins in SCH_3138 mutants

This approach follows similar methodologies to those used in assessing recombinant attenuated Salmonella vaccines, where challenge studies evaluate protection rates and tissue pathology .

What is the potential of SCH_3138 as an antigen in recombinant Salmonella vaccine development?

To evaluate SCH_3138 as a vaccine antigen:

• Antigenicity assessment:

  • In silico epitope prediction

  • ELISA assays using sera from infected animals

  • T-cell epitope mapping

• Expression system development:

  • Construct similar to rSC0016(pS-PlpE) but expressing SCH_3138

  • Verify expression and secretion via Western blot

  • Confirm plasmid stability over multiple passages

• Immunization protocol:

  • Oral administration regimen (e.g., two doses, 3 weeks apart)

  • Measure antigen-specific responses:

    • Mucosal immunity (IgA in intestinal lavage)

    • Humoral immunity (serum IgG titers)

    • Cellular immunity (mixed Th1/Th2 responses)

• Challenge studies:

  • Intraperitoneal challenge with virulent Salmonella

  • Monitor survival rates (aim for >80% protection)

  • Assess tissue pathology reduction

Based on similar studies with the PlpE antigen, researchers should expect that a properly designed recombinant attenuated Salmonella vector can efficiently deliver heterologous antigens in vivo and induce specific immune responses against the target antigen .

What are the evolutionary relationships between SCH_3138 and other protein disulfide oxidoreductases across domains of life?

For phylogenomic analysis:

• Comprehensive sequence analysis:

  • Collect PDO sequences from diverse organisms (bacteria, archaea, eukaryotes)

  • Perform multiple sequence alignment focusing on active site regions

  • Identify conserved motifs and domain architecture

• Phylogenetic reconstruction:

  • Maximum likelihood methods for tree building

  • Bayesian inference to assess node support

  • Character mapping of key functional residues

• Comparative genomic context:

  • Analyze gene neighborhoods across species

  • Identify co-evolved gene clusters

  • Assess horizontal gene transfer events

• Functional evolution analysis:

  • Compare substrate specificities across evolutionary distances

  • Examine conservation of activity profiles (oxidase vs. reductase vs. isomerase)

  • Reconstruct ancestral sequences and test their functions

Evidence suggests that archaeal PDOs may be ancestors of eukaryotic PDI and belong to a novel protein disulfide oxidoreductase family . Similar analysis for SCH_3138 could reveal its evolutionary origins and relationship to other bacterial systems.

What are the common challenges in expressing and purifying functional SCH_3138, and how can researchers overcome them?

Common challenges and solutions:

• Insoluble protein expression:

  • Reduce expression temperature (16-25°C)

  • Co-express with molecular chaperones

  • Optimize induction conditions (concentration, timing)

  • Use solubility-enhancing fusion tags (MBP, SUMO)

• Inactive enzyme recovery:

  • Include redox buffer components during purification

  • Maintain reduced environment with DTT or β-mercaptoethanol

  • Perform on-column refolding for inclusion bodies

  • Use mild detergents to maintain native conformation

• Low yield issues:

  • Optimize codon usage for expression host

  • Scale up culture volumes

  • Test different media formulations

  • Consider fed-batch cultivation

• Plasmid instability:

  • Use balanced-lethal systems as demonstrated with Asd

  • Monitor growth curves to identify growth defects

  • Verify protein expression at various passage numbers

  • Compare growth rates with vector-only controls

Optimization table for expression:

How can researchers optimize experimental conditions for studying SCH_3138 enzymatic activity?

For optimal enzymatic activity characterization:

• Buffer optimization:

  • Screen pH range (pH 5.0-9.0)

  • Test various buffer systems (phosphate, HEPES, Tris)

  • Evaluate salt concentration effects (50-500 mM NaCl)

  • Assess requirement for reducing agents (GSH, DTT)

• Temperature optimization:

  • Determine temperature optima (25-42°C for mesophilic activity)

  • Evaluate thermal stability with differential scanning fluorimetry

  • Measure activity retention after heat treatment

• Cofactor requirements:

  • Test divalent cations (Mg²⁺, Ca²⁺, Zn²⁺, Mn²⁺)

  • Evaluate nucleotide cofactors (ATP, GTP)

  • Assess glutathione redox system components

• Substrate specificity determination:

  • Screen various protein and peptide substrates

  • Measure enzyme kinetics (Km, Vmax, kcat)

  • Develop high-throughput fluorescence-based assays

Based on studies with PfPDO, researchers should prepare for the possibility of cation-dependent ATPase activity with basic pH optimum . Systematic optimization using multi-factorial experimental design approaches can efficiently identify optimal conditions .